- Tytuł:
- Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology April 2021 22(4):463-475
Czasopismo naukowe